Form 8-K Vitae Pharmaceuticals, For: Mar 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Vitae Pharmaceuticals (VTAE) Tops Q4 EPS by 10c
March 3, 2016 5:11 PM ESTVitae Pharmaceuticals (NASDAQ: VTAE) reported Q4 EPS of ($0.52), $0.10 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $92.09 thousand versus the consensus estimate of $120 thousand.
For earnings history and earnings-related data on Vitae Pharmaceuticals (VTAE) click here.
... More